SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-004257
Filing Date
2023-03-03
Accepted
2023-03-03 20:00:01
Documents
2
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 form4-03042023_120347.html 4  
1 form4-03042023_120347.xml 4 5716
2 ex24-03042023_120347.htm EX-24 7716
  Complete submission text file 0001415889-23-004257.txt   14779
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BLUEPRINT MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address
Murray Christopher K. (Reporting) CIK: 0001718648 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 23707067